Table 2.
Gene Name |
Gene Expression |
Correlation With LVW
|
||||||
---|---|---|---|---|---|---|---|---|
Fold Change | P Value | RC | P Value | |||||
Increased expression with hypertrophy | ||||||||
Precursor ANP | 5.18 | 0.0089 | 329.0 | 0.0003 | ||||
Precursor BNP | 2.08 | 0.0012 | 312.0 | 0.0023 | ||||
Prepro-endothelin-1 | 1.86 | 0.0228 | 168.7 | 0.0018 | ||||
Decreased expression with hypertrophy | ||||||||
NF-κB p105* | 0.85 | 0.0297 | NS | |||||
STAT 1* | 0.82 | 0.0264 | NS | |||||
Caveolin 2 | 0.81 | 0.0038 | −248.7 | 0.0069 | ||||
p38* | 0.79 | 0.0130 | NS | |||||
NFATc1* | 0.78 | 0.0324 | NS | |||||
VEGF* | 0.78 | 0.0249 | NS | |||||
S6 kinase† | 0.75 | 0.0219 | −200.4 | 0.0303 | ||||
Phospholamban* | 0.75 | 0.0076 | −213.3 | 0.0233 | ||||
JAK3* | 0.74 | 0.0050 | −262.9 | 0.0123 | ||||
SAPK/JNK* | 0.73 | 0.0256 | NS | |||||
ROCK1* | 0.72 | 0.0216 | NS | |||||
Akt-2* | 0.71 | 0.0010 | −229.0 | 0.0153 | ||||
p47phox | 0.71 | 0.0011 | −390.8 | 0.0171 | ||||
β1-Adrenergic receptor* | 0.70 | 0.0009 | −508.0 | 0.0196 | ||||
SOD2 | 0.69 | 0.0148 | NS | |||||
Calcineurin A | 0.67 | 0.0035 | NS | |||||
Bcl-2 | 0.67 | 0.0075 | NS | |||||
ERK2 | 0.67 | 0.0017 | NS | |||||
ɛPKC* | 0.66 | 0.0045 | −416.2 | 0.0056 | ||||
RBCK1* | 0.65 | 0.0046 | −418.6 | 0.0265 | ||||
Cardiotrophin-1 | 0.63 | 0.0027 | NS | |||||
SERCA2a* | 0.62 | 0.0002 | −506.2 | 0.0059 | ||||
Dystrophin* | 0.61 | 0.0062 | −438.3 | 0.0384 | ||||
Ryanodine receptor 2* | 0.59 | 0.0319 | NS |
Values are indicated with means with P values. List of genes with expression in the myocardium that changed in 11-wk-old hypertensive (HT) rats relative to age-matched normotensive rats is shown at left. Individual regression analysis between change in gene expression and the ratio in left ventricular weight (LVW)/body weight (BW) was carried out. Genes that significantly correlated (P < 0.05) with change in LVW/BW are listed at right. RC, regression coefficient; ANP, atrial natriuretic peptide; BNP, brain natriuretic peptide; NS, not significant; NFAT, nuclear factor of activated T-cells; ROCK, Rho-associated kinase-β; RBCK, RBCC protein interacting with PKC; SERCA2a, sarco(endo)plasmic reticulum Ca2+-ATPase 2a.
Genes with expression that went back to normal in 17-wk-old HT rats;
genes with expression upregulated over control in 17-wk-old HT rats.